1. Up Front

   Up Front 23 December 2023 Pages: 221 - 222

   

2. Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges

   • Scott C. Mackenzie
   • Chris A. R. Sainsbury
   • Deborah J. Wake

   Review Open access 18 November 2023 Pages: 223 - 235

   

3. A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective

   • Johan Jendle
   • Peter Adolfsson
   • Lutz Heinemann

   Review Open access 02 December 2023 Pages: 236 - 245

   

4. Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists

   • Gianluigi Savarese
   • Felix Lindberg
   • Stefan D. Anker

   Review Open access 21 December 2023 Pages: 246 - 262

   

5. Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial

   • Domenico Tricò
   • Maria Chiara Masoni
   • Andrea Natali

   Article Open access 16 November 2023 Pages: 263 - 274

   

6. A diminished sciatic nerve structural integrity is associated with distinct peripheral sensory phenotypes in individuals with type 2 diabetes

   • Christoph M. Mooshage
   • Dimitrios Tsilingiris
   • Zoltan Kender

   Article Open access 29 November 2023 Pages: 275 - 289

   

7. HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives

   • Alessandra Petrelli
   • Federica Cugnata
   • Jay M. Sosenko

   Article Open access 02 November 2023 Pages: 290 - 300

   

8. Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies

   • Frida Emanuelsson
   • Shoaib Afzal
   • Marianne Benn

   Article Open access 14 December 2023 Pages: 301 - 311

   

9. Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes

   • Marzena Gajecka
   • Pawel Gutaj
   • Ewa Wender-Ozegowska

   Article Open access 29 November 2023 Pages: 312 - 326

   

10. Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas

    • Sarah Meulebrouck
    • Victoria Scherrer
    • Amélie Bonnefond

    Short Communication Open access 05 December 2023 Pages: 327 - 332

    

11. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention

    • Emilie Moens de Hase
    • Audrey M. Neyrinck
    • Patrice D. Cani

    Article Open access 28 October 2023 Pages: 333 - 345

    

12. Habitual carbohydrate intake is not correlated with circulating β-hydroxybutyrate levels in pregnant women with overweight and obesity at 28 weeks' gestation

    • Helen L. Tanner
    • Hui Ting Ng
    • Marloes Dekker Nitert

    Article Open access 16 November 2023 Pages: 346 - 355

    

13. RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine

    • Michael G. Miskelly
    • Andreas Lindqvist
    • Nils Wierup

    Article Open access 30 November 2023 Pages: 356 - 370

    

14. Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia

    • Judit Castillo-Armengol
    • Flavia Marzetta
    • Bernard Thorens

    Article Open access 28 November 2023 Pages: 371 - 391

    

15. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study

    • Catriona M. Farrell
    • Alison D. McNeilly
    • Rory J. McCrimmon

    Article Open access 27 November 2023 Pages: 392 - 402

    

16. Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia

    • Judit Castillo‑Armengol
    • Flavia Marzetta
    • Bernard Thorens

    Correction Open access 11 January 2024 Pages: 403 - 403